Terms: = Prostate cancer AND CREB1, ENSG00000118260, 1385 AND Prognosis
3 results:
1. ASCL1-mediated ferroptosis resistance enhances the progress of castration-resistant prostate cancer to neurosecretory prostate cancer.
Nie J; Zhang P; Liang C; Yu Y; Wang X
Free Radic Biol Med; 2023 Aug; 205():318-331. PubMed ID: 37355053
[TBL] [Abstract] [Full Text] [Related]
2. E-Cadherin Represses Anchorage-Independent Growth in Sarcomas through Both Signaling and Mechanical Mechanisms.
Jolly MK; Ware KE; Xu S; Gilja S; Shetler S; Yang Y; Wang X; Austin RG; Runyambo D; Hish AJ; Bartholf DeWitt S; George JT; Kreulen RT; Boss MK; Lazarides AL; Kerr DL; Gerber DG; Sivaraj D; Armstrong AJ; Dewhirst MW; Eward WC; Levine H; Somarelli JA
Mol Cancer Res; 2019 Jun; 17(6):1391-1402. PubMed ID: 30862685
[TBL] [Abstract] [Full Text] [Related]
3. Post genome-wide association studies functional characterization of prostate cancer risk loci.
Jiang J; Cui W; Vongsangnak W; Hu G; Shen B
BMC Genomics; 2013; 14 Suppl 8(Suppl 8):S9. PubMed ID: 24564736
[TBL] [Abstract] [Full Text] [Related]
